Form D · Other Health Care

NEURONASCENT INC

Clarksville, MD · CIK 0001445328

Offering snapshot reported Mar 18, 2015 · SEC filing

Reported sold
$1.2M
Offering amount: $3M
Investors reported
1
Form D · investor count
Minimum accepted
$113K
Reported outside-investor minimum
First sale
Mar 3, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 18, 2015Initial$1,200,000No comparison1SEC filing
Dec 3, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Sep 15, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-236117
A portion of the total amount sold consists of a warrant which has been issued but its effectiveness is subject to certain conditions which have not yet been met.

Source: Form D, filed Mar 18, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Maurice Gagnon Director
Judith Kelleher Andersson Director, Executive
Kathleen Mattis Director, Executive
Robin Oegerle Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
6030 Day Break Circle A150 Pmb 244
Clarksville, MD, 21029